← Eichor
Study identifier: NCT07715968 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Turbine-based CO2 Insufflator Pediatric Feasibility Study

Condition: Laparoscopy · Pneumoperitoneum  ·  Sponsor: Erasmus Medical Center

PhaseNA
Planned participants12
Who can joinAll sexes, N/A to 18 Years
Healthy volunteersNo

About this study

A novel CO2 insufflator, the turbine-based insufflator, has been developed to improve minimal invasive surgery. Turbine technology permits accurate pressure control resulting in an intra-abdominal volume that is dynamically adapted to ventilation. In addition, oscillometric measurements are performed to measure the abdominal compliance of the patient. This feasibility trial primarly aims to evaluate the technologic feasibility during pediatric laparoscopic surgery. Secondary outcomes are pressure stability, comparison of intra-abdominal pressure stability between the standard CO2 insufflator and turbine-based insufflator, and comparison of ventiliation pressures between these insufflators.

This description comes directly from the study's public registry record.

Talk to the study team

A.I. Jong  ·  +31107037641  ·  a.i.dejong@erasmusmc.nl

J. Vlot  ·  +31107039568

Always discuss trial participation with your own doctor first.

Locations (1)

Erasmus MC, University Medical Center RotterdamRotterdam, South Holland, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07715968